April 2026 Straumann expanded its dental biomaterials and implant care portfolio by advancing solutions focused on implant maintenance, infection management, and improved long-term implant outcomes. The company continued research and development activities supporting prevention and treatment of peri-implant complications.
February 2026 Dentsply Sirona expanded its dental solutions portfolio by introducing advancements in implant dentistry technologies and clinical support systems. The company continued focusing on improving implant success rates through better diagnostics, treatment planning, and maintenance solutions.
January 2026 Geistlich Pharma strengthened its regenerative dentistry portfolio by advancing biomaterials used in periodontal and peri-implant treatments. The company continued developing regenerative solutions aimed at supporting tissue healing and improving outcomes in dental procedures.
November 2025 Nobel Biocare expanded its implant dentistry initiatives by strengthening clinical education and technology solutions focused on implant rehabilitation and maintenance. The company continued supporting dental professionals with tools for improved implant care.
September 2025 BioHorizons expanded its dental implant product portfolio by advancing implant surface technologies and treatment solutions designed to improve osseointegration and reduce complications associated with implant procedures.
July 2025 Institut Straumann AG increased investments in digital dentistry and implant treatment solutions, supporting improved diagnosis, monitoring, and personalized treatment approaches for implant-related conditions.